Page last updated: 2024-10-30

mechlorethamine and Protein-Losing Enteropathies

mechlorethamine has been researched along with Protein-Losing Enteropathies in 1 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vincent, PC1
Reeve, TS1
Brittle, N1
Nicholls, A1
Richards, M1

Other Studies

1 other study available for mechlorethamine and Protein-Losing Enteropathies

ArticleYear
The effect of cytotoxic drugs on serum albumin in the rat.
    The Australian journal of experimental biology and medical science, 1967, Volume: 45, Issue:4

    Topics: Animals; Blood Protein Disorders; Blood Protein Electrophoresis; Body Weight; Cyclophosphamide; Mala

1967